Integrated Transcriptome and Metabolomic Analysis Reveal Anti-Angiogenic Properties of Disarib, a Novel Bcl2-Specific Inhibitor

Transcriptomic profiling of several drugs in cancer cell lines has been utilised to obtain drug-specific signatures and guided combination therapy to combat drug resistance and toxicity. Global metabolomics reflects changes due to altered activity of enzymes, environmental factors, etc. Integrating...

Descripción completa

Detalles Bibliográficos
Autores principales: Manjunath, Meghana, Swaroop, Sai, Pradhan, Sai Sanwid, Rao K, Raksha, Mahadeva, Raghunandan, Sivaramakrishnan, Venketesh, Choudhary, Bibha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316176/
https://www.ncbi.nlm.nih.gov/pubmed/35885991
http://dx.doi.org/10.3390/genes13071208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316176/
https://www.ncbi.nlm.nih.gov/pubmed/35885991
http://dx.doi.org/10.3390/genes13071208

Ejemplares similares